Maxime Loo
YOU?
Author Swipe
View article: Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer
Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer Open
The purpose of this study was to assess the prognostic value of 18F-FDG PET parameter variation between baseline and 42 Gy (PET2) of radiochemotherapy at 6 mo and 1 y of evaluation in patients with stage III inoperable nonsmall cell lung c…
View article: Erratum to ‘Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes’ [The Breast (2023) 102–109]
Erratum to ‘Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes’ [The Breast (2023) 102–109] Open
The publisher regret the lines and rows of the tables were shifted. The below are correct.Table 1Patient and tumor characteristics at oligometastatic disease diagnosis (n = 102).Total (patients)No-LATLATp-valueN = 102N = 62N = 40Age (years…
View article: Dose-Response Effect and Dose-Toxicity in Stereotactic Radiotherapy for Brain Metastases: A Review
Dose-Response Effect and Dose-Toxicity in Stereotactic Radiotherapy for Brain Metastases: A Review Open
For more than two decades, stereotactic radiosurgery has been considered a cornerstone treatment for patients with limited brain metastases. Historically, radiosurgery in a single fraction has been the standard of care but recent technical…